Mobile Site ›

Clopidogrel Platelet Function Tests

Caveats and Controversies



Subscribe

Receive notification when new Hot Topics are published:

Controversy for Clopidogrel

Slide 32

December 2011

In March 2010, the FDA added a "Boxed Warning" to the drug label for clopidogrel based on a study of healthy subjects – 10 each of ultrarapid, extensive (normal), intermediate and poor metabolizers.

Controversy for Clopidogrel

 


Jump to section:


Key